GILD vs WAT · P/E 18, rev $7.80B vs P/E 32, rev $3.17B
Gilead Sciences Inc (GILD) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported WAT revenue for 2025-12-31 was $3.17B. Net income was $642.6M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the GILD and WAT stock pages for the full models.
Not investment advice.